vTv Therapeutics (VTVT) EBT Margin Growth (5y) (2019 - 2026)
Analysis
vTv Therapeutics (VTVT) EBT Margin Growth (5y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 66,602.00 |
| Dec 31, 2024 | 7.22 Mn |
| Mar 31, 2024 | -15,954.00 |
| Dec 31, 2022 | -6.17 Mn |
| Jun 30, 2022 | 5.77 Mn |
| Mar 31, 2022 | 4.72 Mn |
| Dec 31, 2021 | -6.93 Mn |
| Sep 30, 2021 | 3.55 Mn |
| Jun 30, 2021 | -131,313.00 |
| Mar 31, 2021 | 299,524.00 |
| Dec 31, 2020 | 491,848.00 |
| Sep 30, 2020 | -2.48 Mn |
| Mar 31, 2020 | -6.99 Mn |
| Dec 31, 2019 | -9.75 Mn |
| Sep 30, 2019 | -7.30 Mn |
| Jun 30, 2019 | 332,472.00 |